Nasopharyngeal carcinoma MRI: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Nasopharyngeal carcinoma}} | {{Nasopharyngeal carcinoma}} | ||
{{CMG}} {{AE}}{{Faizan}} | |||
==Overview== | |||
MRI is more sensitive to [[perineural]] spread and for demonstrating early the bone marrow changes of infiltration (see normal bone marrow signal of the clivus), although not all bone marrow changes represent [[tumor]] extension. Similarly dural thickening may be both evidence of tumour infiltration or reactive [[hyperplasia]]. | |||
==MRI== | |||
MRI is more sensitive to [[perineural]] spread and for demonstrating early the bone marrow changes of infiltration (see normal bone marrow signal of the clivus), although not all bone marrow changes represent [[tumor]] extension. Similarly dural thickening may be both evidence of tumour infiltration or reactive [[hyperplasia]]. | |||
*T1: typically isointense to muscle | |||
*T2 | |||
**isointense to somewhat hyperintense to muscle | |||
**fat saturation is helpful 5 | |||
**fluid in the middle ear is a helpful marker | |||
*T1 C+ (Gd) | |||
**post contrast sequences should be fat saturated | |||
**prominent heterogeneous enhancement is typical | |||
**perineural extension should be sought | |||
Post radiotherapy fibrosis can be distinguished from recurrent / residual tumour on MR if the fibrosis is mature. In such cases fibrotic scarring is of low signal intensity on T2 and does not demonstrate enhancement. Early fibrotic change cannot be distinguished from residual/recurrent tumour as both may be hyperintense on T2 and demonstrate enhancement. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Revision as of 20:05, 8 September 2015
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma MRI On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma MRI |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
MRI is more sensitive to perineural spread and for demonstrating early the bone marrow changes of infiltration (see normal bone marrow signal of the clivus), although not all bone marrow changes represent tumor extension. Similarly dural thickening may be both evidence of tumour infiltration or reactive hyperplasia.
MRI
MRI is more sensitive to perineural spread and for demonstrating early the bone marrow changes of infiltration (see normal bone marrow signal of the clivus), although not all bone marrow changes represent tumor extension. Similarly dural thickening may be both evidence of tumour infiltration or reactive hyperplasia.
- T1: typically isointense to muscle
- T2
- isointense to somewhat hyperintense to muscle
- fat saturation is helpful 5
- fluid in the middle ear is a helpful marker
- T1 C+ (Gd)
- post contrast sequences should be fat saturated
- prominent heterogeneous enhancement is typical
- perineural extension should be sought
Post radiotherapy fibrosis can be distinguished from recurrent / residual tumour on MR if the fibrosis is mature. In such cases fibrotic scarring is of low signal intensity on T2 and does not demonstrate enhancement. Early fibrotic change cannot be distinguished from residual/recurrent tumour as both may be hyperintense on T2 and demonstrate enhancement.